Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from Haoxi Health Technology Limited Class A ( (HAO) ) is now available.
Haoxi Health Technology Limited, a company engaged in the health technology sector, announced the successful closing of a private placement on October 22, 2025. The company sold 5,217,391 Class A ordinary shares at $0.23 per share, raising $1.2 million in gross proceeds. These funds are intended for working capital and general corporate purposes, potentially strengthening the company’s financial position and operational capabilities.
The most recent analyst rating on (HAO) stock is a Hold with a $1.50 price target. To see the full list of analyst forecasts on Haoxi Health Technology Limited Class A stock, see the HAO Stock Forecast page.
Spark’s Take on HAO Stock
According to Spark, TipRanks’ AI Analyst, HAO is a Neutral.
The overall score reflects a combination of strong valuation, with the stock appearing undervalued, and moderate financial performance, highlighted by revenue growth but hampered by cash flow issues. Technical analysis indicates a lack of strong momentum, contributing to the overall risk profile.
To see Spark’s full report on HAO stock, click here.
More about Haoxi Health Technology Limited Class A
Average Trading Volume: 471,474
Technical Sentiment Signal: Sell
Learn more about HAO stock on TipRanks’ Stock Analysis page.